[go: up one dir, main page]

NO20020153L - Bruk av interleukin-18 inhibitorer for å hemme tumormetastase - Google Patents

Bruk av interleukin-18 inhibitorer for å hemme tumormetastase

Info

Publication number
NO20020153L
NO20020153L NO20020153A NO20020153A NO20020153L NO 20020153 L NO20020153 L NO 20020153L NO 20020153 A NO20020153 A NO 20020153A NO 20020153 A NO20020153 A NO 20020153A NO 20020153 L NO20020153 L NO 20020153L
Authority
NO
Norway
Prior art keywords
interleukin
inhibitors
tumor metastasis
inhibit tumor
inhibit
Prior art date
Application number
NO20020153A
Other languages
English (en)
Other versions
NO20020153D0 (no
NO329827B1 (no
Inventor
Charles Dinarello
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20020153D0 publication Critical patent/NO20020153D0/no
Publication of NO20020153L publication Critical patent/NO20020153L/no
Publication of NO329827B1 publication Critical patent/NO329827B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20020153A 1999-07-22 2002-01-11 Anvendelse av inhibitorer av IL-18 produksjon og/eller dets virkning ved fremstilling av medikamenter for a hemme metastase av melanom, og anvendelse av en ekspresjonsvektor som koder for en inhibitor for IL-18 produksjon og deller dets virkning ved fremstillingen av medikamenter for a hemme metastase av melanom NO329827B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (3)

Publication Number Publication Date
NO20020153D0 NO20020153D0 (no) 2002-01-11
NO20020153L true NO20020153L (no) 2002-03-11
NO329827B1 NO329827B1 (no) 2011-01-03

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020153A NO329827B1 (no) 1999-07-22 2002-01-11 Anvendelse av inhibitorer av IL-18 produksjon og/eller dets virkning ved fremstilling av medikamenter for a hemme metastase av melanom, og anvendelse av en ekspresjonsvektor som koder for en inhibitor for IL-18 produksjon og deller dets virkning ved fremstillingen av medikamenter for a hemme metastase av melanom

Country Status (31)

Country Link
US (1) US7741276B2 (no)
EP (1) EP1206274B1 (no)
JP (1) JP4827352B2 (no)
KR (1) KR100682219B1 (no)
CN (1) CN1173736C (no)
AR (1) AR024907A1 (no)
AT (1) ATE363288T1 (no)
AU (1) AU782478B2 (no)
BG (1) BG65800B1 (no)
BR (1) BR0012675A (no)
CA (1) CA2380216C (no)
CY (1) CY1107932T1 (no)
CZ (1) CZ302114B6 (no)
DE (2) DE60035049T2 (no)
DK (1) DK1206274T3 (no)
EA (1) EA005419B1 (no)
EE (1) EE04838B1 (no)
ES (1) ES2186596T3 (no)
HK (1) HK1048248B (no)
HU (1) HU228780B1 (no)
IL (2) IL131047A0 (no)
MX (1) MXPA02000838A (no)
NO (1) NO329827B1 (no)
NZ (1) NZ516535A (no)
PL (1) PL202477B1 (no)
PT (1) PT1206274E (no)
SK (1) SK287522B6 (no)
TR (1) TR200200169T2 (no)
UA (1) UA73745C2 (no)
WO (1) WO2001007480A2 (no)
ZA (1) ZA200200390B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK12942002A3 (sk) * 2000-02-10 2003-05-02 Abbott Laboratories Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
AU2002211744B8 (en) 2000-10-11 2008-03-20 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
AU2003299919B2 (en) * 2002-10-08 2009-08-06 Ares Trading S.A. The use of cytokine able to bind IL-18BP and of inhibiting the activity of a second cytokine
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ES2370417T3 (es) 2005-06-03 2011-12-15 Ares Trading S.A. Producción de una proteína de unión a il-18 recombinante.
PL1891088T3 (pl) 2005-06-10 2012-03-30 Ares Trading Sa Sposób oczyszczania białka wiążącego IL-18
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
AU2023236289A1 (en) 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
WO2025003753A1 (en) 2023-06-26 2025-01-02 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ256171A (en) * 1992-09-02 1996-12-20 Isis Pharmaceuticals Inc Treating diseases amenable to treatment through modulating intercellular adhesion molecule metabolism or synthesis using oligonucleotides
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
CN1269722A (zh) * 1997-03-18 2000-10-11 Basf公司 调节对皮质类固醇反应的方法及组合物
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
DK1206274T3 (da) 2007-08-13
ATE363288T1 (de) 2007-06-15
CA2380216C (en) 2012-01-31
BR0012675A (pt) 2002-04-09
JP4827352B2 (ja) 2011-11-30
BG65800B1 (bg) 2009-12-31
BRPI0012675B1 (pt) 2001-02-01
EE04838B1 (et) 2007-06-15
HU228780B1 (en) 2013-05-28
EE200200032A (et) 2003-02-17
NO20020153D0 (no) 2002-01-11
CZ2002195A3 (cs) 2002-06-12
CN1173736C (zh) 2004-11-03
WO2001007480A2 (en) 2001-02-01
NZ516535A (en) 2004-04-30
HUP0202107A3 (en) 2005-01-28
ES2186596T1 (es) 2003-05-16
NO329827B1 (no) 2011-01-03
CY1107932T1 (el) 2013-09-04
HUP0202107A2 (en) 2002-10-28
HK1048248A1 (en) 2003-03-28
BG106311A (en) 2002-08-30
PL202477B1 (pl) 2009-06-30
DE1206274T1 (de) 2002-11-14
EA200200189A1 (ru) 2002-12-26
US20080003216A1 (en) 2008-01-03
UA73745C2 (en) 2005-09-15
KR20020027493A (ko) 2002-04-13
AR024907A1 (es) 2002-10-30
DE60035049T2 (de) 2007-09-27
ZA200200390B (en) 2003-04-30
US7741276B2 (en) 2010-06-22
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
AU5843200A (en) 2001-02-13
CZ302114B6 (cs) 2010-10-20
CA2380216A1 (en) 2001-02-01
BRPI0012675B8 (no) 2021-05-25
IL131047A0 (en) 2001-01-28
EA005419B1 (ru) 2005-02-24
MXPA02000838A (es) 2002-07-30
SK882002A3 (en) 2002-07-02
AU782478B2 (en) 2005-08-04
EP1206274A2 (en) 2002-05-22
WO2001007480A3 (en) 2001-05-10
EP1206274B1 (en) 2007-05-30
ES2186596T3 (es) 2007-11-16
TR200200169T2 (tr) 2002-06-21
CN1364086A (zh) 2002-08-14
PL353732A1 (en) 2003-12-01
DE60035049D1 (de) 2007-07-12
PT1206274E (pt) 2007-07-06
SK287522B6 (sk) 2011-01-04
KR100682219B1 (ko) 2007-02-12
IL147675A (en) 2009-05-04

Similar Documents

Publication Publication Date Title
ATE355836T1 (de) Inhibitoren der mucin-synthese
EE200100509A (et) Aminopürimidiinid kui sorbitooldehüdrogenaasi inhibiitorid
DK1175400T3 (da) Renininhibitorer
ATE364592T1 (de) Tyrosinderivate
DK1114051T3 (da) Inhibitorer for p38
NO20002316L (no) Additiver til inhibering av gasshydratdannelse
NO20016319D0 (no) VLA-4 inhibitor-forbindelser
NO20020742L (no) Innskrenkning av innretninger for å lyddempe operasjoner
ATE363478T1 (de) Renin inhibitoren
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
NO20020153L (no) Bruk av interleukin-18 inhibitorer for å hemme tumormetastase
NO20032283L (no) Belegg for å hindre erosjon av brönnhullskomponenter
ATE434619T1 (de) Thienodibenzazulenverbindungen als tumornekrosefaktorhemmer
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
FR2816843B1 (fr) Inhibiteurs de l'enzyme 5 alpha-reductase
IL131002A0 (en) An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
NO20005322L (no) Fremgangsmåte for å öke effektiviteten av handel
NO20034245D0 (no) Aromataseinhibering for å öke kunstig befruktning
SI1206274T1 (sl) Uporaba zaviralcev interlevkina-18 za zaviranje tumorske metastaze
NO20013669D0 (no) Reverse hydroksamatinhibitorer av matriks metalloproteinaser
NO20014697L (no) Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris
EP1674100A4 (en) ANGIOGENESIS INHIBITORS
DE60012208D1 (de) Type 1 inhibitorkristalle als inhibitoren des natrium-protonen austauschs
AU2001286861A1 (en) Use of methylphenidate compounds to enhance memory

Legal Events

Date Code Title Description
MK1K Patent expired